176 related articles for article (PubMed ID: 9489976)
41. Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokinetics.
Bursztyn M; Kadr H; Tilvis R; Martina B; Oigman W; Talberg J; Kobrin I
Am Heart J; 1997 Aug; 134(2 Pt 1):238-47. PubMed ID: 9313603
[TBL] [Abstract][Full Text] [Related]
42. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
[TBL] [Abstract][Full Text] [Related]
43. Different effects of calcium antagonist and beta-blocker therapy on left-ventricular diastolic function in ischemic heart disease. A direct comparison of the impact of mibefradil and atenolol.
Hassager C; Thygesen K; Grande P; Fischer Hansen J; Mickley H; Gustafsson I; Skagen K; Steensgaard-Hansen F
Cardiology; 2001; 96(2):65-71. PubMed ID: 11740134
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): a new generation of calcium antagonists? Mibefradil International Study Group.
Bernink PJ; Prager G; Schelling A; Kobrin I
Hypertension; 1996 Mar; 27(3 Pt 1):426-32. PubMed ID: 8698449
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea.
Heitmann J; Grote L; Knaack L; Köhler U; Hinder M; Peter JH
Eur J Clin Pharmacol; 1998; 54(9-10):691-6. PubMed ID: 9923569
[TBL] [Abstract][Full Text] [Related]
46. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
47. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Freedman SB; Daxini BV; Noyce D; Kelly DT
J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
[TBL] [Abstract][Full Text] [Related]
48. The short life and rapid death of a novel antihypertensive and antianginal agent.
Krum H; McNeil JJ
Med J Aust; 1998 Oct; 169(8):408-9. PubMed ID: 9830386
[No Abstract] [Full Text] [Related]
49. A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles. Mibefradil International Study Group.
Viskoper RJ; Bernink PJ; Schelling A; Ribeiro AB; Kantola IM; Wilkins MR; Kobrin I
J Hum Hypertens; 1997 Jun; 11(6):387-93. PubMed ID: 9249234
[TBL] [Abstract][Full Text] [Related]
50. Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group.
Bittar N
Clin Ther; 1997; 19(5):954-62. PubMed ID: 9385483
[TBL] [Abstract][Full Text] [Related]
51. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
52. A comparison of the safety and efficacy of mibefradil and nifedipine SR in patients with renal disease and hypertension.
Woittiez AJ; Huysmans FT; Bailey R; Robson RA; Mion Júnior D; Villa G; Kobrin I
Clin Nephrol; 1998 Mar; 49(3):160-6. PubMed ID: 9543597
[TBL] [Abstract][Full Text] [Related]
53. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
54. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
Mazzotta G; Falcidieno M; Ravera E; Vecchio C
G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
[TBL] [Abstract][Full Text] [Related]
55. Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris.
Klein G; Pfafferott C; Beil S; Gehring J; Niemelä M; Kendall MJ
J Clin Pharm Ther; 1997; 22(5-6):371-8. PubMed ID: 19160722
[TBL] [Abstract][Full Text] [Related]
56. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
Sandmann S; Spitznagel H; Chung O; Xia QG; Illner S; Jänichen G; Rossius B; Daemen MJ; Unger T
Cardiovasc Res; 1998 Aug; 39(2):339-50. PubMed ID: 9798519
[TBL] [Abstract][Full Text] [Related]
57. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
58. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
59. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
[TBL] [Abstract][Full Text] [Related]
60. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Stone PH; Ware JH; DeWood MA; Gore JM; Eich RH; Pietro DA; Parisi AF; Nesto RW; Boden WE; Sharma SC
Am Heart J; 1988 Oct; 116(4):961-71. PubMed ID: 2902779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
